Insmed Inc
(NAS:INSM)
$
69.61
-1.06 (-1.5%)
Market Cap: 12.45 Bil
Enterprise Value: 12.18 Bil
PE Ratio: 0
PB Ratio: 25.75
GF Score: 67/100 Insmed Inc at Goldman Sachs Healthcare Conference Transcript
Jun 14, 2023 / 08:20PM GMT
Release Date Price:
$19.29
(-0.67%)
Andrea R. Tan
Goldman Sachs Group, Inc., Research Division - Research Analyst
Perfect. Thanks, everyone, for joining us. Andrea Tan, biotech analyst at Goldman Sachs. She we're pleased to have Will Lewis, CEO of Insmed with us. Thanks again, Will, for joining us.
William H. Lewis
Insmed Incorporated - President, CEO & Chairman
Glad to be here.
Questions & Answers
Andrea R. Tan
Goldman Sachs Group, Inc., Research Division - Research Analyst
Maybe if we can start big picture. Insmed, 4 pillars, very, very active. Maybe walk us through a high-level overview of each of those pillars, the progress you're making there and then the expectations for these key data reads that are coming from each one.
William H. Lewis
Insmed Incorporated - President, CEO & Chairman
Sure. I think the next 12 months is probably the most exciting time in the history of the company, and I've been at the company now coming up on 11 years. We've really spent the last several years
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot